VanEck Biotech (Mexico) Performance
| BBH Etf | MXN 2,248 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and VanEck Biotech are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, VanEck Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
VanEck |
VanEck Biotech Relative Risk vs. Return Landscape
If you would invest 224,800 in VanEck Biotech ETF on September 30, 2024 and sell it today you would earn a total of 0.00 from holding VanEck Biotech ETF or generate 0.0% return on investment over 90 days. VanEck Biotech ETF is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all etfs have less volatile historical return distribution than VanEck Biotech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
VanEck Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Biotech's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as VanEck Biotech ETF, and traders can use it to determine the average amount a VanEck Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BBH |
Based on monthly moving average VanEck Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Biotech by adding VanEck Biotech to a well-diversified portfolio.
VanEck Biotech Fundamentals Growth
VanEck Etf prices reflect investors' perceptions of the future prospects and financial health of VanEck Biotech, and VanEck Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VanEck Etf performance.
| Price To Earning | 16.72 X | |||
| Price To Book | 2.76 X | |||
| Price To Sales | 4.78 X | |||
About VanEck Biotech Performance
Evaluating VanEck Biotech's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if VanEck Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if VanEck Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| VanEck Biotech ETF generated a negative expected return over the last 90 days | |
| The fund yields -19.0% to date and shows negative annual yield of 0.0% | |
| VanEck Biotech ETF holds 99.97% of its assets under management (AUM) in equities |
Additional Information and Resources on Investing in VanEck Etf
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.